Extracellular Signal-Related Kinase Biomarker Development in Autism
Completed
Conditions studied: Autism Spectrum Disorders
In brief
The purpose of this research study is to establish a way to help the development of targeted treatments in autism spectrum disorders. This may also help in early diagnosis of autism and may possibly predict severity. The study will compare subject's ERK (extracellular signal-related kinase) signaling to age- and gender-matched neurotypical controls and Intelligence quotient (IQ)-matched developmental disabilities.
Key facts
- Study ID
- NCT01850459
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 213
- Starts
- 2013-01-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2017-04-19
Who can join
Age: 3 and older, up to 25. Sex: any. Healthy volunteers: accepted.
Where it is running
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.